Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
23Andme Holding Co. (ME)
23Andme Holding Co. (ME)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 466,505
  • Shares Outstanding, K 479,105
  • Annual Sales, $ 299,490 K
  • Annual Income, $ -311,660 K
  • 60-Month Beta 1.37
  • Price/Sales 1.43
  • Price/Cash Flow N/A
  • Price/Book 0.68
Trade ME with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.72
  • Most Recent Earnings -0.16 on 11/08/23
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 94.50% ( -10.17%)
  • Historical Volatility 109.69%
  • IV Percentile 64%
  • IV Rank 42.08%
  • IV High 171.96% on 10/13/23
  • IV Low 38.22% on 09/15/23
  • Put/Call Vol Ratio 0.77
  • Today's Volume 163
  • Volume Avg (30-Day) 654
  • Put/Call OI Ratio 0.12
  • Today's Open Interest 65,543
  • Open Int (30-Day) 63,529

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr N/A
See More
  • Average Estimate N/A
  • Number of Estimates N/A
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7101 +36.81%
on 11/09/23
0.9988 -2.73%
on 12/04/23
+0.0397 (+4.26%)
since 11/03/23
3-Month
0.6101 +59.24%
on 10/25/23
1.1600 -16.25%
on 09/11/23
-0.0585 (-5.68%)
since 09/05/23
52-Week
0.6101 +59.24%
on 10/25/23
3.2300 -69.92%
on 12/06/22
-2.2185 (-69.55%)
since 12/05/22

Most Recent Stories

More News
3 Pharma Stocks to Capitalize on With Potential Upside

The pharma industry’s prospects look bright, thanks to rising demand for innovative drugs. Thus, pharma stocks with potential upside, like GSK plc (GSK), Johnson & Johnson (JNJ), and Bristol-Myers Squibb...

BMY : 50.38 (+0.80%)
GSK : 36.36 (-0.74%)
JNJ : 158.50 (-0.24%)
ME : 0.9731 (-0.06%)
Why Pancreatic Cancer is No Longer a Death Sentence: Emerging Therapies to Watch

USA News Group – Despite being a relatively rare form of cancer, pancreatic cancer remains one of the deadliest in the oncology field, the third leading cause of cancer death in the USA. Still not fully...

ONCY : 1.3919 (-1.28%)
ONC.TO : 1.90 (+0.53%)
LLY : 588.50 (+0.48%)
RHHBY : 35.7800 (+1.02%)
BNTX : 98.73 (-1.18%)
ME : 0.9731 (-0.06%)
Fighting the Silent Killer: Innovative Therapies for Pancreatic Cancer on the Rise

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(OTCQX:RHHBY),(NASDAQ:BNTX),(NASDAQ:ME) EQNX::TICKER_END

LLY : 588.50 (+0.48%)
ONCY : 1.3919 (-1.28%)
ONC.TO : 1.90 (+0.53%)
RHHBY : 35.7800 (+1.02%)
BNTX : 98.73 (-1.18%)
ME : 0.9731 (-0.06%)
Better AI Biotech Stock: Recursion Pharmaceuticals vs. 23andMe

Both businesses have a lot to prove.

RXRX : 7.12 (-3.91%)
ME : 0.9731 (-0.06%)
Why 23andMe Holding Stock Plummeted by 13% Today

Investors reacted sharply and not well to the company's inaugural set of fiscal 2024 earnings.

ME : 0.9731 (-0.06%)
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating 23andMe Holding Co. for Potential Breaches of Fiduciary Duty By Its Board of Directors

/PRNewswire/ -- Purcell & Lefkowitz LLP, a class action law firm dedicated to representing shareholders nationwide, is investigating a potential breach of...

ME : 0.9731 (-0.06%)
Better Diversified Biotech Stock: 23andMe vs. Fulgent Genetics

Neither has a traditional business model, but that could be an asset for both.

ME : 0.9731 (-0.06%)
FLGT : 26.23 (-4.51%)
3 Key Biotech Trends for 2023 And Beyond

New opportunities are becoming apparent, but so are fresh risks in the biotech field.

SDGR : 31.85 (-1.27%)
ME : 0.9731 (-0.06%)
DNA : 1.3150 (-6.07%)
23andMe Publishes Inaugural Environmental, Social and Governance Report

/PRNewswire/ -- 23andMe Holding Co. (Nasdaq: ME) ("23andMe"), a leading human genetics and biopharmaceutical company with a mission to help people access,...

ME : 0.9731 (-0.06%)
3 Key Ways That Artificial Intelligence Will Disrupt Biotech Stocks

Biotechs with an AI strategy are likely to be the first to flourish from the disruptions.

ME : 0.9731 (-0.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 48% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

23andMe Inc. is a consumer genetics and research company. It involved in discovery programs rooted in human genetics across a spectrum of disease areas, including oncology, respiratory and cardiovascular diseases, in addition to other therapeutic areas. 23andMe Inc., formerly known as VG Acquisition...

See More

Key Turning Points

3rd Resistance Point 1.1271
2nd Resistance Point 1.0630
1st Resistance Point 1.0183
Last Price 0.9731
1st Support Level 0.9095
2nd Support Level 0.8454
3rd Support Level 0.8007

See More

52-Week High 3.2300
Fibonacci 61.8% 2.2292
Fibonacci 50% 1.9201
Fibonacci 38.2% 1.6109
Last Price 0.9731
52-Week Low 0.6101

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar